A Randomized, Double Blind, Placebo-controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients.
Phase of Trial: Phase IV
Latest Information Update: 17 Mar 2016
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 05 Nov 2013 Planned End Date changed from 1 Sep 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.
- 16 Nov 2012 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 13 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.